High risk patient for post-ERCP pancreatitis (PEP)
Conditions
Interventions
Insertion of a prophylactic pancreatic stent up to pancreatic body or tail
Insertion of a prophylactic pancreatic stent in pancreatic head
Sponsors
Department of Gastroenterology, Fukushima Medical University, School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The cases who were performed ERCP to investigate or treat pancreaticobiliary diseases. The patients has more than one of the below risk factors and are placed ERCP guidewire to main pancreatic duct. 1. Past history of pancreatitis 2. Endoscopic pancreatography 3. Precut of Vater papilla 3. The invasive pancreaticobiliary investigation (brush cytology, biopsy, IDUS, cygology of pancreatic juice, etc...) 4. The biliary metallic stent insertion
Exclusion criteria
Exclusion criteria: 1. Vater papilla that has already performed endoscopic procedures (EST, stenting, EPBD, etc) 2. The imposiblity of endoscopic access to Vater papilla 3. The past history of gastorectomy 4. Pancreas divism 5. Intraductal papillary mucinous neoplasm 6. Theraperutic pancreatic stent insertion 7. Chronic pancreatitis, pancreatic head cancer 8. Postampllectomy 9. Malfusion of pancreaticobiliary ducts 10. Allergies to drugs that are used in ERCP 11. Acute pancreatitis, or serum hyperamylasemia (pancratic isozyme more than 150 IU/L) 12. Not sufficiently sedated
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The occurrance of PEP | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The highest pancreatic isozyme of serum amylase within a week after ERCP 2. The comparison of ERCP rlated procedures (EST, Precut of Vater papilla, EPBD, endoscopic stone removal, biliary drainage, IDUS, pancratic investigation, the time of procedure) | — |
Countries
Japan
Contacts
Public ContactMitsuru Sugimoto
School of Medicine, Fukushima Medical University Department of Gastroenterology
Outcome results
None listed